Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609)

HKG:6609 Revenue

Shanghai HeartCare Medical Technology Corporation had revenue of 291.03M CNY in the half year ending June 30, 2026, with 126.51% growth. This brings the company's total for the last twelve months to 513.79M, up 53.40% year-over-year. In the year 2025, Shanghai HeartCare Medical Technology Corporation had annual revenue of 408.29M with 46.92% growth. That makes Shanghai HeartCare Medical Technology Corporation the 24,794th largest company in the world by revenue and 1,477th in Hong Kong.

• Revenue (ttm): 513.79M CNY
• Revenue Growth: +53.40%
• P/S Ratio: 3.33
• Revenue / Employee: 1.21M CNY
• Employees: 425
• Market Cap: 1.98B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Geography

Chart

• Mainland China 391.38M 95.9%
• Others 16.90M 4.1%

Fiscal year ended Dec 31, 2025 See the full HKG:6609 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	408.29M	130.39M	46.92%
Dec 31, 2024	277.90M	45.56M	19.61%
Dec 31, 2023	232.34M	49.31M	26.94%
Dec 31, 2022	183.03M	92.94M	103.17%
Dec 31, 2021	90.09M	75.53M	518.66%

Data Source: S&P Global Market Intelligence Last updated: Sep 23, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 21, 2026

Data Sources Report a data error